Diagnosis and Management of Hepatic Encephalopathy in Fulminant Hepatic Failure

Clin Liver Dis. 2015 Aug;19(3):565-76. doi: 10.1016/j.cld.2015.04.006. Epub 2015 May 26.

Abstract

Hepatic encephalopathy (HE) is associated with cerebral edema (CE), increased intracranial pressure (ICP), and subsequent neurologic complications; it is the most important cause of morbidity and mortality in fulminant hepatic failure. The goal of therapy should be early diagnosis and treatment of HE with measures to reduce CE. A combination of clinical examination and diagnostic modalities can aid in prompt diagnosis. ICP monitoring and transcranial Doppler help diagnose and monitor response to treatment. Transfer to a transplant center and intensive care unit admission with airway management and reduction of CE with hypertonic saline, mannitol, hypothermia, and sedation are recommended as a bridge to liver transplantation.

Keywords: Ammonia; Fulminant hepatic failure; Hepatic encephalopathy; Hyperammonemia.

Publication types

  • Review

MeSH terms

  • Acetylcysteine / therapeutic use
  • Ammonia / blood*
  • Brain Edema / etiology
  • Brain Edema / physiopathology
  • Brain Edema / therapy*
  • Free Radical Scavengers / therapeutic use
  • Gastrointestinal Agents / therapeutic use
  • Hepatic Encephalopathy / diagnosis*
  • Hepatic Encephalopathy / etiology
  • Hepatic Encephalopathy / physiopathology
  • Hepatic Encephalopathy / therapy*
  • Humans
  • Intracranial Pressure
  • Lactulose / therapeutic use
  • Liver Failure, Acute / complications*
  • Liver Failure, Acute / drug therapy
  • Liver Failure, Acute / physiopathology
  • Neuroimaging
  • Neuropsychological Tests
  • Nutritional Support
  • Rifamycins / therapeutic use
  • Rifaximin

Substances

  • Free Radical Scavengers
  • Gastrointestinal Agents
  • Rifamycins
  • Lactulose
  • Ammonia
  • Rifaximin
  • Acetylcysteine